Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis

Keyphrases

• 4-dinitrobenzene 66%
• Adhesion Molecules 100%
• Anti-inflammatory Activity 16%
• Antioxidation 100%
• Astragalus Membranaceus 100%
• Attenuation 16%
• Colitis 33%
• Colon Tissue 33%
• Colonic Lesions 16%
• Consecutive Days 16%
• Deprivation 16%
• Enema 33%
• Experimental Colitis 100%
• GSH Content 16%
• GSH Level 16%
• Hapten 16%
• Histological Damage 16%
• Intercellular Adhesion molecule-1 (ICAM-1) 33%
• Lesion Area 33%
• Macroscopic Lesions 16%
• Molecular Synthesis 100%
• Myeloperoxidase 16%
• Myeloperoxidase Activity 16%
• Nitrite Oxide 33%
• Once-daily 16%
• P-selectin 33%
• Preventive Potential 16%
• Protective Effect 16%
• Protein Expression 33%
• Reduced Glutathione 16%
• Sprague-Dawley Rats 16%
• Sulfonic Acid 66%
• Therapeutic Potential 16%
• Twice Daily 16%
• Western Blot Analysis 16%
• Xanthine Oxidase 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Anti-Inflammatory Drug 20%
• Astragalus membranaceus 100%
• Astragalus Membranaceus Extract 20%
• Cell Adhesion Proteins 100%
• Colitis 40%
• Enema 40%
• Experimental Colitis 100%
• Glutathione 20%
• Hapten 20%
• Intercellular Adhesion Molecule 1 40%
• Myeloperoxidase 40%
• Nitrite 40%
• Nitrobenzene Derivative 80%
• P-Selectin 40%
• Sprague Dawley Rat 20%
• Sulfonic Acid 80%
• Synthetase 40%
• Western Blot 20%
• Xanthine Oxidase 20%